MEDTECHVISION 2025

Maimah Karmo – Founder, Tigerlily Foundation

Maimah Karmo will share her powerful story of being a nineteen year survivor of breast cancer. On February 28, 2006, at 4:45 p.m., Maimah was diagnosed with Stage 2 triple negative breast cancer. She had no family history and was 32-years old. While undergoing her second round of chemotherapy, she made a promise to God that if she survived, she would create an organization to educate, empower, advocate for and support young women affected by breast cancer. After her second treatment, Tigerlily Foundation was born.

Tigerlily provides breast health, educational, empowerment, wellness and transformational programs working to end disparities. A first-generation immigrant from Liberia, she is a leader in the women’s health field, developing national and global health initiatives for women.

Moderator: 

Bhairavi Parikh – CEO, Clarity Health Alliance

Panelists:

Carla Goulart Peron, MD MBA – Chief Medical Officer, Philips

Gretchen Brown – VP, Chief Nursing Information Officer, Stanford Health

Lucile Blaise Sauvage – SVP, Strategy & Business Development, Resmed

Stephanie Franklin-Thomas PhD, MBA, BA, CISA, NACD.DC – VP, Global Chief Information Security Officer, Medtronic

This panel will explore the profound and multifaceted impact of Artificial Intelligence (AI) across the entire Medtech landscape. We will delve into how AI is driving innovation in tangible ways, such as product development, enhancing patient care delivery and revolutionizing operational effectiveness within the industry.

Liz Powell, Esq., MPH – Founder, G2G Consulting and Women’s Health Advocates

Laura Mauri, MD, MSc – Senior Vice President, Chief Scientific and Medical Officer at Medtronic

Moderator: 

Nada O. Hanafi, MSc, MPH – Founder, MedTech Strategy Advisors, LLC, Co-Founder, MedTech Color

Moderator: 

Monica Jain, MD, FACS – CEO, Dissect Health

Panelists:

Catherine (Cat) Jennings – President, Peripheral Vascular, Peripheral Interventions, Boston Scientific Corporation

Cynthia Yee – Partner, Vensana Capital

Gabriele Niederauer, PhD – CEO & Co-Founder, Freyya, Inc.

Ye Bu – Managing Director, Global Strategy & Business Development, GE Healthcare

The Medtech landscape is experiencing a surge in strategic activity, with M&A and partnerships driving growth and innovation. This panel will explore successful deal strategies, such as key factors behind effective transactions as well as smart capital allocation & future growth strategies, specifically touching on how medtech companies are utilizing capital from M&A, leveraging partnerships to accelerate innovation and balancing internal development with external collaborations for long-term success.

Moderator: 

Kim Rodriguez – CEO, Vitara Biomedical

Panelists:

Kathy Akagha, MPH – Sr. Director, Clinical Affairs, Patient Activation, ID and Engagement, Edwards Lifesciences

Annisah Um’rani – General Counsel, Otsuka Precision Health, Inc.

Carole (Gahafer) Roth – Chief People Officer, Imperative Care

Monika E. Hagen, MD MBA – Consultant Physician and Lecturer, Bariatric Surgery, Department of Surgery, University Hospital Geneva

As the Medtech industry evolves at an unprecedented pace, companies are reshaping their corporate identities to stay ahead. This panel explores how leaders are rebranding for innovation, embedding sustainability and diversity into their missions and aligning with the growing demands for patient-centered care. We will also dive into strategies for building resilience through organizational changes and workforce evolution. Learn how Medtech organizations are moving beyond traditional models and embracing a forward-thinking vision to drive impact and success in the future of healthcare.